First Boston Pharma

Silab Inc, located in Hazlet, NJ, is a leading provider of high-performance vegetable derived ingredients for the global beauty care industry. With advanced technology and a commitment to sustainability, Silab delivers ingredients that offer desirable skin feel, long shelf life, and biological functionality to market-leading formulations worldwide. Their focus on creating socially minded beauty care products sets them apart in the industry. Silab Inc offers a wide range of ingredients, including raw materials, actives, functional ingredients, pigments, polymers, preservatives, and surfactants, catering to various end-user sectors such as air care, color cosmetics, hair care, household cleaning, oral care, OTC medicated products, packaging, personal cleansers, skin care, and sun care. With their expertise and dedication to innovation, Silab Inc is a trusted partner for the development and marketing of high-quality beauty care products.Generated from the website

Hovione, based in Hightstown, is a leading Contract Development and Manufacturing Company specializing in assisting Pharmaceutical Customers in the development and market launch of new and off-patent drugs. The company prides itself on excelling in challenging tasks to provide its customers with unique solutions that are not readily available elsewhere in the industry. Generated from their website's infomation

ARKAY Therapeutics is a pioneering pharmaceutical company based in Hightstown, NJ, at the forefront of modern innovative medicine. Their mission is to change the current trajectory of Type 2 diabetes by developing groundbreaking therapies that address the failures of existing treatments and improve patient outcomes. With a patient-centric approach, ARKAY focuses on preserving beta cell function, decreasing insulin resistance, and providing sustained glycemic control. Their flagship product, TriGlytza, targets the multidimensional pathophysiology of Type 2 diabetes and aims to restore beta cell function, prevent beta cell failure, and maintain insulin sufficiency. ARKAY Therapeutics stands out in the diabetes space by offering a unique and comprehensive solution to the complex metabolic disorder. Unlike traditional drugs that treat Type 2 diabetes in isolation, TriGlytza considers comorbidities and coexisting conditions, providing a holistic approach to treatment. Backed by scientific rationale and supported by clinical studies, TriGlytza has the potential to revolutionize the management of Type 2 diabetes and improve the lives of millions of patients worldwide.Generated from the website